Stay updated on Nivolumab for High-Risk Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk Prostate Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Related Topics section no longer displays links for Prostate Cancer and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-05T03:22:51.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added related topics: Prostate cancer and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-29T02:11:31.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A consolidated Locations section was added, listing Massachusetts and New Hampshire sites (replacing the previous separate Massachusetts Locations and New Hampshire Locations). The HHS Vulnerability Disclosure link was removed and the site revision tag updated from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-22T00:44:39.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added. Prostate cancer and related topic MedlinePlus Genetics were removed; Revision: v3.3.1 was removed.
    Difference
    0.2%
    Check dated 2025-11-30T15:33:03.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page's metadata was updated to include a 'Prostate cancer' tag and related topic 'MedlinePlus Genetics', and the revision label changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-23T14:54:58.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The government funding operating-status notice has been removed from the page. Core trial information such as description, eligibility, design, and outcome measures remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-16T14:32:29.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.